Live Breaking News & Updates on ஆளுகை தேவைகள்|Page 6

Stay updated with breaking news from ஆளுகை தேவைகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Investegate |Olink Proteomics AB Announcements | Olink Proteomics AB: Olink Holding AB (publ) Announces Pricing of Public Offering of American Depositary Shares by Selling Shareholders


DISCLAIMER
Solely for the purposes of the product governance requirements contained within: (a) Regulation (EU) No 600/2014 as it forms part of domestic U.K. law by virtue of the European Union Withdrawal Act (“EUWA”) (“U.K. MiFIR”); and (b) the FCA Handbook Product Intervention and Product Governance Sourcebook (together, the “U.K. MiFIR Product Governance Requirements”), and disclaiming all and any liability, whether arising in tort, contract or otherwise, which any “manufacturer” (for the purposes of the U.K. MiFIR Product Governance Requirements) may otherwise have with respect thereto, the shares have been subject to a product approval process, which has determined that the shares are: (i) compatible with an end target market of retail clients as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of the EUWA, professional clients as defined in U.K. MiFIR, and eligible counterparties as defined in the ....

New York , United States , United Kingdom , Uppsala Lan , Stina Thorman , Exchange Commission On , Exchange Commission , Prospectus Department , Goldman Sachs Bank Europe , Goldman Sachs Co , Olink Holding , Commission Delegated Directive , Morgan Stanley Co , Announces Pricing , Public Offering , American Depositary Shares , Depositary Shares , Morgan Stanley , Goldman Sachs , North America , Securities Litigation Reform Act , Registration Statement , European Union Withdrawal Act , Product Intervention , Product Governance Sourcebook , Governance Requirements ,

Olink Holding AB (publ) Announces Pricing of Public Offering of American Depositary Shares by ...


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Olink Holding AB (publ) Announces Pricing of Public Offering of American Depositary Shares by .
Olink Proteomics ABJuly 15, 2021 GMT
UPPSALA, Sweden, July 15, 2021 (GLOBE NEWSWIRE) Olink Holding AB (publ) (Nasdaq: OLK) (“Olink” or the “Company”), today announced the pricing of a public offering of 7,500,000 American Depositary Shares, each representing one common share of the Company (the “ADSs”), to be sold by certain selling shareholders of the Company, at a price to the public of $31.00 per ADS. In addition, certain selling shareholders have granted the underwriters a 30-day option to purchase up to 1,125,000 additional ADSs. The selling shareholders will receive all of the net proceeds from the offering and Olink will not receive any proceeds. The offering is expected to close on or about July 19, 2021, subject to the satisfaction of customary closing condit ....

New York , United States , United Kingdom , Uppsala Lan , Stina Thorman , Exchange Commission On , Exchange Commission , Prospectus Department , Goldman Sachs Bank Europe , Goldman Sachs Co , Olink Holding , Commission Delegated Directive , Morgan Stanley Co , Depositary Shares , Morgan Stanley , Goldman Sachs , North America , Securities Litigation Reform Act , Registration Statement , European Union Withdrawal Act , Product Intervention , Product Governance Sourcebook , Governance Requirements , Business Sourcebook , Market Assessment , Target Market Assessment ,

Olink Holding AB (publ) Announces Pricing of Public


DISCLAIMER
Solely for the purposes of the product governance requirements contained within: (a) Regulation (EU) No 600/2014 as it forms part of domestic U.K. law by virtue of the European Union Withdrawal Act (“EUWA”) (“U.K. MiFIR”); and (b) the FCA Handbook Product Intervention and Product Governance Sourcebook (together, the “U.K. MiFIR Product Governance Requirements”), and disclaiming all and any liability, whether arising in tort, contract or otherwise, which any “manufacturer” (for the purposes of the U.K. MiFIR Product Governance Requirements) may otherwise have with respect thereto, the shares have been subject to a product approval process, which has determined that the shares are: (i) compatible with an end target market of retail clients as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of the EUWA, professional clients as defined in U.K. MiFIR, and eligible counterparties as defined in the ....

New York , United States , United Kingdom , Uppsala Lan , Stina Thorman , Exchange Commission On , Exchange Commission , Prospectus Department , Goldman Sachs Bank Europe , Goldman Sachs Co , Olink Holding , Commission Delegated Directive , Morgan Stanley Co , Depositary Shares , Morgan Stanley , Goldman Sachs , North America , Securities Litigation Reform Act , Registration Statement , European Union Withdrawal Act , Product Intervention , Product Governance Sourcebook , Governance Requirements , Business Sourcebook , Market Assessment , Target Market Assessment ,